[Informed sources introduce the details of Pfizer's failure in the new crown drug negotiations: Pfizer executives left before the negotiations] I don't know if some people who touted the so-called "special drug" Paxlovid on the Internet some time ago have the support of capital forces? Judging from the negotiation process, it seems that Pfizer is still not sincere enough.
According to people familiar with the matter interviewed by the Beijing News:
By the time Paxlovid was talked, executives such as vice presidents had left, a fact that sent a clear signal to the negotiating health care parties. Combined with the fact that the company has no intention of reducing prices during the negotiation process, the willingness expressed by the enterprise has been quite obvious."
@Lee's Signature Opinion:
Pfizer is not in health insurance Some people are happy, in fact, the rich do not matter, the impact is ordinary people, think of these are probably rich people, if not, then it is either stupid or bad.
Virology expert Chang Rongshan told "China Entrepreneur" that Pfizer's Paxlovid mainly reduces the risk of severe disease, that is, it is mainly for moderate patients and there are such high-risk groups that may become severe, and need to be taken early, if it has become severe, then taking drugs has little effect.
Pfizer is really a miracle medicine, Pfizer is really so concerned about the people, it should be vigorously promoted in the United States, first protect every American! Don't have a medicine that the United States itself uses, a medicine that no one in the United States uses ... Entering the Chinese market at a high price, but also want to enter medical insurance?
